Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
Home > (11alpha,13E)-(+)-11alpha,16-Dihydroxy-16-methyl-9-oxoprost-13E-en-1-oic acid methyl ester > (11alpha,13E)-(+)-11alpha,16-Dihydroxy-16-methyl-9-oxoprost-13E-en-1-oic acid methyl ester(59122-46-2)

(11alpha,13E)-(+)-11alpha,16-Dihydroxy-16-methyl-9-oxoprost-13E-en-1-oic acid methyl ester(59122-46-2)

Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
More
Less

Product Identification

Product Name

(11alpha,13E)-(+)-11alpha,16-Dihydroxy-16-methyl-9-oxoprost-13E-en-1-oic acid methyl ester

Synonyms

Cytotec
Methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
Misoprostil
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11a,13E)-

CAS

59122-46-2

Formula

C22H38O5

Molecular Weight

382.54

RTECS

UK8390000

RTECS Class

Drug; Reproductive Effector; Human Data

Merck

12,6297

Beilstein/Gmelin

4155643

More
Less

Physical and Chemical Properties

Appearance

Light yellow oil.

Solubility in water

Insoluble

pKa/pKb

13.92 (pKa)

Usage

Anti-ulcerative.

More
Less

First Aid Measures

Ingestion

Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.

Inhalation

If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.

Skin

Remove contaminated clothing. Wash exposed area with soap and water. If symptoms persist, seek medical attention. Launder clothing before reuse.

Eyes

If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.

More
Less

Handling and Storage

Storage

Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

Handling

All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.

More
Less

Hazards Identification

Inhalation

Hypoxemia and respiratory alkalosis has been observed following an acute overdose.

Ingestion

Gastrointestinal side effects include nausea (2% to 5%), vomiting (0.9%), diarrhea (3% to 13%), abdominal pain (17%), and constipation (0.6% to 2%). Nausea and abdominal cramping were reported in two overdose ingestions.

More
Less

Exposure Controls/Personal Protection

Personal Protection

Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.

Respirators

Use NIOSH/MSHA approved respirator appropriate for exposure of concern.

Exposure Effects

Elevated body temperature, increased pulse, and increased respiratory rate may result from an acute overdose. therapeutic side effects have included headache, dizziness, fatigue, and malaise. Seizures are possible. Tremor was reported in one overdose. Women should be advised not to become pregnant while taking misoprostol. If pregnancy is suspected, use of the product should be discontinued and the pregnancy should be followed very closely (weekly) for the next 4 weeks. <br>Mobius' syndrome (congenital facial paralysis) were reported following maternal misoprostol administration.

More
Less

Fire Fighting Measures

Fire Fighting

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.

More
Less

Accidental Release Measures

Small spills/leaks

Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.

More
Less

Stability and Reactivity

Stability

No data.

Incompatibilities

Strong oxidizing agents.

More
Less

ContactMore

Wuhan Xinru Chemical Co., Ltd.
Tel
15927387915
WebSite
https://www.xinruchem.com
HuBei ShengBaoLai Biological Technology Co., Ltd
Tel
027-59105235
Fax
027-59105235
WebSite
http://www.hubeisbl-bio.com
Hubei Yangyi Xinsheng Biological Medicine Co., LTD
Zhende Chemical Technology (Shanghai) Co., Ltd.
Fax
3004479441
WebSite
https://www.chemicalbook.com/ShowSupplierProductsList187370/0.htm
J & K SCIENTIFIC LTD.
Tel
010-82848833
Fax
86-10-82849933
WebSite
http://www.jkchemical.com